https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 HER2 status predicts for upfront AI benefit: a TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34088 Wed 06 Feb 2019 16:16:15 AEDT ]]> Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19927 Mon 06 Aug 2018 11:18:23 AEST ]]>